Dihydroartemisinin counteracts fibrotic portal hypertension <i>via</i> farnesoid X receptor‐dependent inhibition of hepatic stellate cell contraction
Dihydroartemisinin counteracts fibrotic portal hypertension <i>via</i> farnesoid X receptor‐dependent inhibition of hepatic stellate cell contraction is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Dihydroartemisinin counteracts fibrotic portal hypertension <i>via</i> farnesoid X receptor‐dependent inhibition of hepatic stellate cell contraction have?
Dihydroartemisinin counteracts fibrotic portal hypertension <i>via</i> farnesoid X receptor‐dependent inhibition of hepatic stellate cell contraction has 37 citations in the OpenAlex counts ScholarIQ stores.
When was Dihydroartemisinin counteracts fibrotic portal hypertension <i>via</i> farnesoid X receptor‐dependent inhibition of hepatic stellate cell contraction published?
Dihydroartemisinin counteracts fibrotic portal hypertension <i>via</i> farnesoid X receptor‐dependent inhibition of hepatic stellate cell contraction has 2016 year in the ScholarIQ index.
What is the open-access status of Dihydroartemisinin counteracts fibrotic portal hypertension <i>via</i> farnesoid X receptor‐dependent inhibition of hepatic stellate cell contraction?
Dihydroartemisinin counteracts fibrotic portal hypertension <i>via</i> farnesoid X receptor‐dependent inhibition of hepatic stellate cell contraction has bronze oa status in the ScholarIQ index.
What is the DOI of Dihydroartemisinin counteracts fibrotic portal hypertension <i>via</i> farnesoid X receptor‐dependent inhibition of hepatic stellate cell contraction?
The DOI for Dihydroartemisinin counteracts fibrotic portal hypertension <i>via</i> farnesoid X receptor‐dependent inhibition of hepatic stellate cell contraction is on the source record.
What is the PMID of Dihydroartemisinin counteracts fibrotic portal hypertension <i>via</i> farnesoid X receptor‐dependent inhibition of hepatic stellate cell contraction?
The PMID for Dihydroartemisinin counteracts fibrotic portal hypertension <i>via</i> farnesoid X receptor‐dependent inhibition of hepatic stellate cell contraction is on the source record.
What is the OpenAlex record for Dihydroartemisinin counteracts fibrotic portal hypertension <i>via</i> farnesoid X receptor‐dependent inhibition of hepatic stellate cell contraction?
The OpenAlex for Dihydroartemisinin counteracts fibrotic portal hypertension <i>via</i> farnesoid X receptor‐dependent inhibition of hepatic stellate cell contraction is on the source record.